An LC - Search Results

1

[Analysis of the Effect of TET2 Mutation and SNP on Clinical Characteristics and Prognosis of AML Patients].

Li L, An LC, Chu XX, Liu XQ, Wang L. Li L, et al. Among authors: an lc. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Apr;28(2):453-459. doi: 10.19746/j.cnki.issn.1009-2137.2020.02.016. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020. PMID: 32319378 Chinese.

2

Nasal NK/T cell lymphoma mimicking mucosa-associated lymphoid tissue lymphoma in morphology: A case report.

Yu G, Liu X, Zhou H, An L, Li H, Wu S, Liu Y, Pan X, Qu G, Chu X. Yu G, et al. Oncol Lett. 2019 Nov;18(5):5561-5566. doi: 10.3892/ol.2019.10865. Epub 2019 Sep 13. Oncol Lett. 2019. PMID: 31612064 Free PMC article.

3

Co-existence of t(9;22) and t(8;21) in primary blast phase of chronic myelogenous leukemia: clinical experience and literature review.

Zhang Y, Liu Y, Liu X, An L, Huang B, Li J, Zhang G, Zhang X, Gong J, Yu G, Chu X. Zhang Y, et al. Int J Clin Exp Pathol. 2019 May 1;12(5):1811-1815. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934003 Free PMC article.

4

[Proventive and Therapentic Effects of Endothelial Progenitor Cells on Monocrotaline-Induced Hepatic Vein Occlusion Disease].

An LC, Li XJ, Liu YH, Liu XQ, Zhang YF, Wang YM, Chu XX. An LC, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Feb;28(1):242-247. doi: 10.19746/j.cnki.issn.1009-2137.2020.01.041. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020. PMID: 32027284 Chinese.

5

A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma.

Liu X, Zhang Y, Li K, Liu Y, Xu J, Ma J, An L, Wang H, Chu X. Liu X, et al. Transl Oncol. 2021 Jul;14(7):101085. doi: 10.1016/j.tranon.2021.101085. Epub 2021 Apr 1. Transl Oncol. 2021. PMID: 33813229 Free PMC article.

6

Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients.

Wang L, Chu X, Wang J, An L, Liu Y, Li L, Xu J. Wang L, et al. Turk J Haematol. 2021 Aug 25;38(3):188-194. doi: 10.4274/tjh.galenos.2021.2021.0009. Epub 2021 May 3. Turk J Haematol. 2021. PMID: 33938209 Free PMC article.

7

The mouse model of hepatic veno-occlusive disease.

An L, L X, Chu X, Liu X, Zhang Y, Wang Y, Wang Y, Liu Y. An L, et al. Pak J Pharm Sci. 2021 Nov;34(6(Special)):2391-2400. Pak J Pharm Sci. 2021. PMID: 35039250

8

[Safety and the short-term efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with lymphoma].

An LC, Liu YH, Wang JY, Ma JJ, Xu JQ, Li KM, Wei RX, Sui JR, Feng XY, Liu XQ, Chen LM, Chu XX. An LC, et al. Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):63-65. doi: 10.3760/cma.j.issn.0253-2727.2022.01.012. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35231995 Free PMC article. Chinese. No abstract available.

9

[Effects of liver sinusoid endothelial cell injury in mouse hepatic veno-occlusive disease].

Fang T, An LC, Liu MM, Hua J, Xu KL, Zeng LY. Fang T, et al. Among authors: an lc. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Dec;20(6):1457-62. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 23257453 Chinese.

10

Successful Blinatumomab treatment in an allogeneic hematopoietic stem cell transplant recipient with EBV-related post-transplant lymphoproliferative disorder: A case report and literature review.

Chen S, An L, Han J, Zheng X, Zhang X, Li G, Zhang Y, Cao W, Lv M, Yang D, Jiang E, Pang A, Feng S. Chen S, et al. Transpl Immunol. 2023 Oct;80:101895. doi: 10.1016/j.trim.2023.101895. Epub 2023 Jul 5. Transpl Immunol. 2023. PMID: 37414267 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters